FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044978511> ?p ?o ?g. }

• W2044978511 endingPage "485" @default.
• W2044978511 startingPage "473" @default.
• W2044978511 abstract "Background: Reducing serum total cholesterol (TC) levels using 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in hypercholesterolemic patients has been shown to reduce the incidence of complications of coronary heart disease (CHD). However, few data are available on the potential benefit of reductions in serum cholesterol levels in normocholesterolemic patients with coronary atherosclerosis. Objective: The Prevention of Coronary Sclerosis Study is a single-center study designed to assess the effect of treatment with the HMG-CoA reductase inhibitor pravastatin on progression and regression of angiographically documented coronary atherosclerosis in normocholesterolemic patients with CHD. Methods: A total of 329 patients aged <70 years with CHD were enrolled and classified into 1 of 3 groups based on serum TC level: group 1, TC ≥220 mg/dL; group 2, TC 180–219 mg/dL; and group 3, TC <180 mg/dL. Patients in group 2 were randomized to 1 of 2 subgroups, 2a or 2b. Patients in groups 1 and 2a were given pravastatin 10 mg/d; patients in groups 2b and 3 did not receive cholesterol-lowering drugs. The subsequent coronary events of patients were followed for 2 years and reexamined by coronary angiography (CAG). Both baseline and follow-up CAGs were analyzed by quantitative coronary arteriography at a central laboratory. Results: Decreases in both mean segment diameter (MSD) and minimum obstruction diameter (MOD) in group 2a were significantly less than those in the control group 2b (P = 0.015 and P = 0.023, respectively). The effects on MSD and MOD in group 2a and the low-cholesterol reference group 3 were similar. The incidence of clinical events was 8.9%, 3.7%, 12.1%, and 10.0% in groups 1, 2a, 2b, and 3, respectively, with no significant differences in rates between groups 2a and 2b. Conclusion: The results of this study suggest that cholesterol-lowering therapy with pravastatin may prevent progression of coronary atherosclerosis in normocholesterolemic patients with CHD." @default.
• W2044978511 created "2016-06-24" @default.
• W2044978511 creator A5004357209 @default.
• W2044978511 creator A5008122128 @default.
• W2044978511 creator A5013154675 @default.
• W2044978511 creator A5028379363 @default.
• W2044978511 creator A5030996513 @default.
• W2044978511 creator A5031773545 @default.
• W2044978511 creator A5032545147 @default.
• W2044978511 creator A5034647954 @default.
• W2044978511 creator A5045059471 @default.
• W2044978511 creator A5059011927 @default.
• W2044978511 creator A5088956919 @default.
• W2044978511 creator A5090654717 @default.
• W2044978511 date "2001-06-01" @default.
• W2044978511 modified "2023-09-26" @default.
• W2044978511 title "Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: two-year follow-up of the prevention of coronary sclerosis study" @default.
• W2044978511 cites W1955502234 @default.
• W2044978511 cites W1966817707 @default.
• W2044978511 cites W1968144530 @default.
• W2044978511 cites W1992000409 @default.
• W2044978511 cites W1994875362 @default.
• W2044978511 cites W2028103879 @default.
• W2044978511 cites W2029127038 @default.
• W2044978511 cites W2041390357 @default.
• W2044978511 cites W2046942878 @default.
• W2044978511 cites W2061488209 @default.
• W2044978511 cites W2067435964 @default.
• W2044978511 cites W2069806183 @default.
• W2044978511 cites W2072308694 @default.
• W2044978511 cites W2081995474 @default.
• W2044978511 cites W2082669903 @default.
• W2044978511 cites W2088935147 @default.
• W2044978511 cites W2095750162 @default.
• W2044978511 cites W2104651644 @default.
• W2044978511 cites W2108361166 @default.
• W2044978511 cites W2109397913 @default.
• W2044978511 cites W2112698709 @default.
• W2044978511 cites W2120860913 @default.
• W2044978511 cites W2125933583 @default.
• W2044978511 cites W2131275408 @default.
• W2044978511 cites W2134343469 @default.
• W2044978511 cites W2134627002 @default.
• W2044978511 cites W2155598961 @default.
• W2044978511 cites W2283618120 @default.
• W2044978511 cites W2316856729 @default.
• W2044978511 cites W2322095705 @default.
• W2044978511 cites W2338977280 @default.
• W2044978511 cites W3145321382 @default.
• W2044978511 cites W4238099401 @default.
• W2044978511 cites W4254289289 @default.
• W2044978511 cites W4254582475 @default.
• W2044978511 doi "https://doi.org/10.1016/s0011-393x(01)80058-8" @default.
• W2044978511 hasPublicationYear "2001" @default.
• W2044978511 type Work @default.
• W2044978511 sameAs 2044978511 @default.
• W2044978511 citedByCount "7" @default.
• W2044978511 crossrefType "journal-article" @default.
• W2044978511 hasAuthorship W2044978511A5004357209 @default.
• W2044978511 hasAuthorship W2044978511A5008122128 @default.
• W2044978511 hasAuthorship W2044978511A5013154675 @default.
• W2044978511 hasAuthorship W2044978511A5028379363 @default.
• W2044978511 hasAuthorship W2044978511A5030996513 @default.
• W2044978511 hasAuthorship W2044978511A5031773545 @default.
• W2044978511 hasAuthorship W2044978511A5032545147 @default.
• W2044978511 hasAuthorship W2044978511A5034647954 @default.
• W2044978511 hasAuthorship W2044978511A5045059471 @default.
• W2044978511 hasAuthorship W2044978511A5059011927 @default.
• W2044978511 hasAuthorship W2044978511A5088956919 @default.
• W2044978511 hasAuthorship W2044978511A5090654717 @default.
• W2044978511 hasConcept C104950815 @default.
• W2044978511 hasConcept C126322002 @default.
• W2044978511 hasConcept C134651460 @default.
• W2044978511 hasConcept C164705383 @default.
• W2044978511 hasConcept C168563851 @default.
• W2044978511 hasConcept C181199279 @default.
• W2044978511 hasConcept C185592680 @default.
• W2044978511 hasConcept C2778163477 @default.
• W2044978511 hasConcept C2779519902 @default.
• W2044978511 hasConcept C2991716557 @default.
• W2044978511 hasConcept C3018906752 @default.
• W2044978511 hasConcept C3019004856 @default.
• W2044978511 hasConcept C500558357 @default.
• W2044978511 hasConcept C55493867 @default.
• W2044978511 hasConcept C71924100 @default.
• W2044978511 hasConcept C90924648 @default.
• W2044978511 hasConceptScore W2044978511C104950815 @default.
• W2044978511 hasConceptScore W2044978511C126322002 @default.
• W2044978511 hasConceptScore W2044978511C134651460 @default.
• W2044978511 hasConceptScore W2044978511C164705383 @default.
• W2044978511 hasConceptScore W2044978511C168563851 @default.
• W2044978511 hasConceptScore W2044978511C181199279 @default.
• W2044978511 hasConceptScore W2044978511C185592680 @default.
• W2044978511 hasConceptScore W2044978511C2778163477 @default.
• W2044978511 hasConceptScore W2044978511C2779519902 @default.
• W2044978511 hasConceptScore W2044978511C2991716557 @default.
• W2044978511 hasConceptScore W2044978511C3018906752 @default.
• W2044978511 hasConceptScore W2044978511C3019004856 @default.

• next